What does this research mean for the field?

TRAF7 mutations can occur in fibromyxoid spindle cell tumors of bone, as demonstrated by a case with a TRAF7 p.Y563C mutation. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

What question did this study set out to answer?

To expand the understanding of TRAF7 mutations in fibromyxoid spindle cell tumors, particularly in bone.

March 13, 2026

TRAF7-Mutated Fibromyxoid Spindle Cell Tumor of Bone: An Osseous Case Expanding the Spectrum of TRAF7-Mutated Tumors With Over 20 Years Clinical Follow-Up.

Puntos clave

To expand the understanding of TRAF7 mutations in fibromyxoid spindle cell tumors, particularly in bone.
Reported a case of a 60-year-old woman with a knee lesion detected 20 years prior.
Conducted imaging studies showing tumor growth and destruction.
Performed histological examination and immunohistochemical analysis.
Utilized whole exome sequencing to identify the TRAF7 mutation.
Identified a TRAF7 p.Y563C missense mutation in the tumor.
Observed a spindle cell neoplasm with fibrous to myxoid stroma and rare mitotic figures.
Documented significant clinical follow-up with no local recurrence or distant disease at 2 months post-resection.

Resumen

TRAF7 mutations are a rare occurrence in human cancer and have recently been described in a group of mesenchymal tumors with varying clinical course. Herein, we expand the spectrum of TRAF7-mutated fibromyxoid spindle cell tumors by reporting the first case to arise in bone. A 60-year-old woman presented with right knee pain and was incidentally found to have a left distal femur lesion, which was first detected 20 years prior when it was favored to be benign. Recent imaging studies revealed significant interval growth with focal cortical destruction and soft tissue extension. Histologic examination showed a bland spindle cell neoplasm with fibrous to myxoid stroma. Rare mitotic figures were present; necrosis and marked cytologic atypia were absent. Immunohistochemical work-up showed that the spindle cells only demonstrated focal cytoplasmic staining with L1CAM, and whole exome sequencing identified a TRAF7 p.Y563C missense mutation. The tumor was resected, and the patient is recovering well at 2 months with no evidence of local recurrence or distant disease. This report is the first known case of a TRAF7-mutated fibromyxoid spindle cell tumor of bone with the longest clinical follow-up reported to date.

Preguntar a la IA

Me gusta

Guardar